Objectives-Left ventricular (LV) septal hypertrophy in aortic stenosis raises diagnostic and therapeutic questions. However, the etiology and clinical consequences of this finding have not been well studied. The aim of this study was to perform a morphologic evaluation of the LV in aortic stenosis and to investigate the contributing factors and consequences of septal hypertrophy.Methods-Patients with moderate or severe aortic stenosis were prospectively enrolled. Patients with previous myocardial infarction, wall motion abnormalities, at least moderate valvular regurgitation, known cardiomyopathy, an LV ejection fraction of less than 50%, and age younger than 65 years were excluded.Results-Forty-one patients underwent a final analysis. Septal hypertrophy (LV septal wall thickness 15 mm) was confirmed in 21 of 41 patients. The septal hypertrophy group had higher peak aortic valve velocity, a higher diabetes mellitus rate, and a higher rate and longer duration of hypertension than those without septal hypertrophy. The peak aortic valve velocity (odds ratio, 7.1; 95% confidence interval, 1.4-37.1) and diabetes mellitus (odds ratio, 7.4; 95% confidence interval, 1.2-46.2) were the significant factors associated with septal hypertrophy by multivariate analysis. Intraventricular conduction disturbance on electrocardiography was more frequent in the septal hypertrophy group (P 5 .021).Conclusions-Left ventricular septal hypertrophy was commonly observed in elderly patients with aortic stenosis, and a higher aortic valve velocity, hypertension, and diabetes mellitus were associated factors. Intraventricular conduction disturbance occurred more often in patients with septal hypertrophy than those without, which implies the pathophysiologic consequence. Further studies are needed to determine the impact of septal hypertrophy and intraventricular conduction disturbance on the prognosis of patients after aortic valve interventions.Key Words-aortic stenosis; echocardiography (adult); electrocardiology; magnetic resonance imaging; valvular heart disease A symmetric hypertrophy, especially basal septal hypertrophy, has been identified as a variant in patients with aortic stenosis. However, the etiology and clinical consequences of this entity have not been well investigated: specifically, whether clinical factors such as hypertension, age, and the severity of aortic stenosis predispose patients to septal hypertrophy development and whether this hypertrophy has a causal effect for physiologic abnormalities. When septal thickness is excessive, differential diagnoses of hypertrophic cardiomyopathy or other infiltrative diseases need to be considered. Additionally, septal hypertrophy has an impact on clinical management that may dictate the choice of surgical procedure (traditional